Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Mega Genomics Limited ( (HK:6667) ) has shared an announcement.
Mega Genomics Limited has scheduled a board meeting for 30 January 2026 to review and approve the Group’s audited final results for the financial year ended 31 December 2024 and to consider recommending a final dividend to shareholders. The meeting signals the company is moving toward the formal release of its annual financial performance and potential shareholder returns, developments that will be closely watched by investors assessing the Group’s operational health and capital distribution policy.
More about Mega Genomics Limited
Mega Genomics Limited is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange (stock code: 6667). It operates as a group structure, though this announcement does not specify its particular segment within the genomics or broader life sciences industry.
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.61B
See more data about 6667 stock on TipRanks’ Stock Analysis page.